WELL HEALTH TECHNOLOGIES COR (WELL.CA) Stock Fundamental Analysis
Canada - TSX:WELL - CA94947L1022 - Common Stock
4.88 CAD
-0.01 (-0.2%)
We assign a fundamental rating of 3 out of 10 to WELL. WELL was compared to 15 industry peers in the Health Care Providers & Services industry. WELL has a bad profitability rating. Also its financial health evaluation is rather negative. WELL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year WELL has reported negative net income.
In the past year WELL had a positive cash flow from operations.
In multiple years WELL reported negative net income over the last 5 years.
WELL had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
WELL's Return On Assets of -6.37% is on the low side compared to the rest of the industry. WELL is outperformed by 60.00% of its industry peers.
Looking at the Return On Equity, with a value of -15.57%, WELL is in line with its industry, outperforming 46.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.37% | ||
| ROE | -15.57% | ||
| ROIC | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
WELL's Gross Margin of 39.21% is in line compared to the rest of the industry. WELL outperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of WELL has grown nicely.
The Profit Margin and Operating Margin are not available for WELL so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.21% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
2. Health
2.1 Basic Checks
WELL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WELL has more shares outstanding
WELL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, WELL has an improved debt to assets ratio.
2.2 Solvency
WELL has an Altman-Z score of 1.09. This is a bad value and indicates that WELL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.09, WELL is in line with its industry, outperforming 53.33% of the companies in the same industry.
WELL has a Debt/Equity ratio of 0.68. This is a neutral value indicating WELL is somewhat dependend on debt financing.
WELL's Debt to Equity ratio of 0.68 is fine compared to the rest of the industry. WELL outperforms 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.09 |
ROIC/WACCN/A
WACC8.27%
2.3 Liquidity
WELL has a Current Ratio of 0.93. This is a bad value and indicates that WELL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of WELL (0.93) is better than 73.33% of its industry peers.
A Quick Ratio of 0.92 indicates that WELL may have some problems paying its short term obligations.
The Quick ratio of WELL (0.92) is better than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
WELL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -221.43%.
WELL shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.36%.
Measured over the past years, WELL shows a very strong growth in Revenue. The Revenue has been growing by 94.78% on average per year.
EPS 1Y (TTM)-221.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.7%
Revenue 1Y (TTM)20.36%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%46.69%
3.2 Future
WELL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.87% yearly.
The Revenue is expected to grow by 16.34% on average over the next years. This is quite good.
EPS Next Y51.86%
EPS Next 2Y42.11%
EPS Next 3Y34.36%
EPS Next 5Y15.87%
Revenue Next Year43.56%
Revenue Next 2Y25.75%
Revenue Next 3Y19.49%
Revenue Next 5Y16.34%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
WELL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 16.11 indicates a correct valuation of WELL.
Based on the Price/Forward Earnings ratio, WELL is valued cheaply inside the industry as 86.67% of the companies are valued more expensively.
WELL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 16.11 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WELL is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 25.98 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as WELL's earnings are expected to grow with 34.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.11%
EPS Next 3Y34.36%
5. Dividend
5.1 Amount
No dividends for WELL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:WELL (10/17/2025, 7:00:00 PM)
4.88
-0.01 (-0.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners5.81%
Inst Owner ChangeN/A
Ins Owners22.59%
Ins Owner ChangeN/A
Market Cap1.24B
Analysts81
Price Target7.82 (60.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-368.63%
Min EPS beat(2)-696.08%
Max EPS beat(2)-41.18%
EPS beat(4)0
Avg EPS beat(4)-1069.61%
Min EPS beat(4)-3335.29%
Max EPS beat(4)-41.18%
EPS beat(8)2
Avg EPS beat(8)1698.56%
EPS beat(12)3
Avg EPS beat(12)1044.26%
EPS beat(16)3
Avg EPS beat(16)671.21%
Revenue beat(2)1
Avg Revenue beat(2)0.17%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)1.59%
Revenue beat(4)1
Avg Revenue beat(4)-3.16%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)4
Avg Revenue beat(8)-0.94%
Revenue beat(12)6
Avg Revenue beat(12)-0.37%
Revenue beat(16)10
Avg Revenue beat(16)0.69%
PT rev (1m)0%
PT rev (3m)0.47%
EPS NQ rev (1m)-5.09%
EPS NQ rev (3m)8.21%
EPS NY rev (1m)0%
EPS NY rev (3m)3.87%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)0.52%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 16.11 | ||
| P/S | 1.13 | ||
| P/FCF | N/A | ||
| P/OCF | 267.42 | ||
| P/B | 1.5 | ||
| P/tB | N/A | ||
| EV/EBITDA | 25.98 |
EPS(TTM)-0.51
EYN/A
EPS(NY)0.3
Fwd EY6.21%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.02
OCFY0.37%
SpS4.32
BVpS3.25
TBVpS-2.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.37% | ||
| ROE | -15.57% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.21% | ||
| FCFM | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score2
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 8.34 | ||
| Cap/Depr | 25.5% | ||
| Cap/Sales | 1.94% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 6.83% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 1.09 |
F-Score2
WACC8.27%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-221.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.7%
EPS Next Y51.86%
EPS Next 2Y42.11%
EPS Next 3Y34.36%
EPS Next 5Y15.87%
Revenue 1Y (TTM)20.36%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%46.69%
Revenue Next Year43.56%
Revenue Next 2Y25.75%
Revenue Next 3Y19.49%
Revenue Next 5Y16.34%
EBIT growth 1Y-144.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year286.51%
EBIT Next 3Y64.16%
EBIT Next 5Y42.51%
FCF growth 1Y-124.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.87%
OCF growth 3Y-22.85%
OCF growth 5YN/A